|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03886 TOWN HEALTH
Nominal 
0.250 0.000 (0.000%) | 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Turnover | 1,785,563 | -2.630% | 1,833,795 | 1,833,038 | 1,535,580 | 1,483,892 |
| Cost of Sales | (1,321,410) | -1.856% | (1,346,406) | (1,331,090) | (1,121,134) | (1,012,631) |
| Gross Profit | 464,153 | -4.767% | 487,389 | 501,948 | 414,446 | 471,261 |
| 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | (117,763) | |
| Share of Results of Asso. & JCEs | 19,159 | -- | (7,155) | (5,319) | (14,826) | 32,844 | |
| Profit / (Loss) before Taxation | 104,998 | -- | (121,691) | (120,863) | 82,503 | 126,508 | |
| Taxation | (40,198) | 10.083% | (36,516) | (38,226) | (32,981) | (51,436) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (50,423) | 10.830% | (45,496) | (35,121) | (34,233) | (53,059) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 14,377 | -- | (203,703) | (194,210) | 15,289 | 22,013 | |
| 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Finance Costs / (Income) | (20,928) | 65.256% | (12,664) | (8,284) | (16,809) | (12,425) |
| Depreciation & Amortisation | 131,354 | -3.884% | 136,662 | 145,629 | 127,560 | 122,221 |
| Directors' Emoluments | 13,388 | 13.989% | 11,745 | 16,101 | 12,805 | 3,751 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 0.210 | -- | -3.010 | -2.870 | 0.210 | 0.290 |
| DPS (cts) | 0.180 | -- | 0.120 | 0.120 | 0.120 | 0.150 |
| Dividend Payout Ratio (%) | 85.714% | -- | -- | -- | 57.143% | 51.724% |
| Cash flow per share ($) | -- | -- | 0.036 | 0.037 | 0.006 | 0.023 |
| NBV per share ($) | 0.443 | -- | 0.439 | 0.479 | 0.511 | 0.512 |
| Remarks: | Real time quote last updated: 09/04/2026 10:13 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 14,377 |
| %Change | -- |
| EPS / (LPS) | HKD 0.002 |
| NBV Per Share ($) | HKD 0.443 |